ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 144 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $172 | -17.7% | 53,100 | +34.8% | 0.01% | -25.0% |
| Q3 2023 | $209 | +49.3% | 39,400 | +168.0% | 0.01% | +60.0% |
| Q2 2023 | $140 | -13.6% | 14,700 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $162 | -16.5% | 14,700 | +12.2% | 0.01% | -25.0% |
| Q4 2022 | $194 | -99.9% | 13,100 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $250,000 | -10.4% | 13,100 | 0.0% | 0.01% | -7.7% |
| Q2 2022 | $279,000 | +10.7% | 13,100 | 0.0% | 0.01% | +18.2% |
| Q1 2022 | $252,000 | -7.4% | 13,100 | 0.0% | 0.01% | -8.3% |
| Q4 2021 | $272,000 | – | 13,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |